nodakenin has been researched along with B16 Melanoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, S; Bae, S; Kim, TJ; Lee, JH; Yoon, Y | 1 |
1 other study(ies) available for nodakenin and B16 Melanoma
| Article | Year |
|---|---|
Nodakenin Inhibits Melanogenesis Via the ERK/MSK1 Signaling Pathway.
Topics: alpha-MSH; Animals; Cell Line, Tumor; Coumarins; Culture Media, Conditioned; Glucosides; MAP Kinase Signaling System; Melanins; Melanoma; Melanoma, Experimental; Mice; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase; Signal Transduction | 2023 |